标题
Current and future therapies for type 1 diabetes
作者
关键词
-
出版物
DIABETOLOGIA
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-02-19
DOI
10.1007/s00125-021-05398-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents
- (2020) Christine Ferrara-Cook et al. DIABETES CARE
- SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action
- (2020) Milton Packer DIABETES CARE
- Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
- (2020) Nicklas J Johansen et al. Lancet Diabetes & Endocrinology
- Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial
- (2020) Husam Ghanim et al. DIABETES OBESITY & METABOLISM
- The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: analysis of LEADER and SUSTAIN 6 trials
- (2020) Lawrence A. Leiter et al. DIABETES OBESITY & METABOLISM
- Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming
- (2020) Adrian Villalba et al. Frontiers in Endocrinology
- 3-LB: Golimumab (GLM) Preserves ß-Cell Function and Reduces Insulin Use and Hypoglycemia in Children and Young Adults with Recently Diagnosed Type 1 Diabetes (T1D): The Phase 2 T1GER Study
- (2020) TERESA QUATTRIN et al. DIABETES
- Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study
- (2020) Michelle Rosenzwajg et al. DIABETOLOGIA
- Current progress in stem cell therapy for type 1 diabetes mellitus
- (2020) Shuai Chen et al. Stem Cell Research & Therapy
- Adjunct Therapies in Treatment of Type 1 Diabetes
- (2020) Itivrita Goyal et al. Journal of Diabetes
- Long-term viability through selective permeability
- (2020) Ken Coppieters et al. Nature Biomedical Engineering
- The impact of pharmacological and lifestyle interventions on body weight in people with type 1 diabetes: A systematic review and meta‐analysis
- (2020) Saniya Tandon et al. DIABETES OBESITY & METABOLISM
- Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?
- (2020) Roberto Mallone et al. DIABETOLOGIA
- The healthy exocrine pancreas contains preproinsulin-specific CD8 T cells that attack islets in type 1 diabetes
- (2020) Christine Bender et al. Science Advances
- An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice
- (2020) Liliane Khoryati et al. Science Immunology
- Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
- (2020) Bart O. Roep et al. Nature Reviews Endocrinology
- International Consensus on Risk Management of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Treated with Sodium-Glucose Cotransporter (SGLT) Inhibitors
- (2019) Thomas Danne et al. DIABETES CARE
- Excess Cardiovascular Risk in Type 1 Diabetes Mellitus
- (2019) John R. Petrie et al. CIRCULATION
- Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
- (2019) Michael J. Haller et al. DIABETES
- SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme Caution
- (2019) Joseph I. Wolfsdorf et al. DIABETES CARE
- Targeting Interleukin-6 Signaling in Clinic
- (2019) Sujin Kang et al. IMMUNITY
- Cardiovascular Risk in Type 1 Diabetes Mellitus
- (2019) Jonathan Schofield et al. Diabetes Therapy
- 233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7
- (2019) KATHERINE R. TUTTLE et al. DIABETES
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
- (2019) Anette-Gabriele Ziegler et al. BMJ Open
- WITHDRAWN: IDF Diabetes Atlas: Worldwide Estimates of Incidence, Prevalence and Mortality of Type 1 Diabetes in Children and Adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Christopher C. Patterson et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
- (2019) Brendon L Neuen et al. Lancet Diabetes & Endocrinology
- Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
- (2019) Manuela Battaglia et al. DIABETES CARE
- Advances in technology for management of type 1 diabetes
- (2019) Roy W Beck et al. LANCET
- IL-6 is present in beta and alpha cells in human pancreatic islets: Expression is reduced in subjects with type 1 diabetes
- (2019) Sakthi Rajendran et al. CLINICAL IMMUNOLOGY
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial
- (2019) Thomas F. Dejgaard et al. DIABETES OBESITY & METABOLISM
- Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes
- (2019) Somayeh Sabouri et al. JOURNAL OF AUTOIMMUNITY
- SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks
- (2019) Simeon I Taylor et al. Lancet Diabetes & Endocrinology
- Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance
- (2018) Eddie A. James et al. DIABETES
- Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
- (2018) John B. Buse et al. DIABETES CARE
- Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1cin New-Onset Type 1 Diabetes
- (2018) Michael J. Haller et al. DIABETES CARE
- Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
- (2018) Chantal Mathieu et al. DIABETES CARE
- A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials
- (2018) Vanita R. Aroda DIABETES OBESITY & METABOLISM
- Obesity and diabetes-Not only a simple link between two epidemics
- (2018) Agata Chobot et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Verapamil and beta cell function in adults with recent-onset type 1 diabetes
- (2018) Fernando Ovalle et al. NATURE MEDICINE
- Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances
- (2018) Emma L. Smith et al. Frontiers in Immunology
- Enteroviral Infections as a Trigger for Type 1 Diabetes
- (2018) Teresa Rodriguez-Calvo Current Diabetes Reports
- Enteroviral infections in the pathogenesis of type 1 diabetes: new insights for therapeutic intervention
- (2018) Sarah J Richardson et al. CURRENT OPINION IN PHARMACOLOGY
- Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study
- (2018) Matthew C. Riddle et al. DIABETES CARE
- Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact and Mechanisms
- (2018) Karen D Corbin et al. ENDOCRINE REVIEWS
- Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
- (2018) Araz Rawshani et al. LANCET
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study
- (2018) Paresh Dandona et al. DIABETES CARE
- Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
- (2018) Julio Rosenstock et al. DIABETES CARE
- Addition of GLP‐1RA therapy to Insulin in C‐peptide Positive Patients With Type 1 Diabetes
- (2018) Nitesh D Kuhadiya et al. DIABETES OBESITY & METABOLISM
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- The challenge of modulating β-cell autoimmunity in type 1 diabetes
- (2018) Mark A Atkinson et al. Lancet Diabetes & Endocrinology
- Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine
- (2018) Bart O Roep et al. Lancet Diabetes & Endocrinology
- Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
- (2018) Jordan Rowlands et al. Frontiers in Endocrinology
- Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes
- (2017) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Autoreactive T cells in type 1 diabetes
- (2017) Alberto Pugliese JOURNAL OF CLINICAL INVESTIGATION
- Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
- (2017) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intralymphatic Injection of Autoantigen in Type 1 Diabetes
- (2017) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
- (2017) Satish K. Garg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
- (2017) John R Petrie et al. Lancet Diabetes & Endocrinology
- Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2017) Weihao Wang et al. Diabetes Therapy
- Type 1 diabetes mellitus
- (2017) Anastasia Katsarou et al. Nature Reviews Disease Primers
- T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes
- (2017) Adam L. Burrack et al. Frontiers in Endocrinology
- Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2017) Weihao Wang et al. Diabetes Therapy
- The viral paradigm in type 1 diabetes: Who are the main suspects?
- (2016) Teresa Rodriguez-Calvo et al. AUTOIMMUNITY REVIEWS
- Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2
- (2016) Connor J. Dwyer et al. Current Diabetes Reports
- Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial
- (2016) Bo Ahrén et al. DIABETES CARE
- Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
- (2016) Chantal Mathieu et al. DIABETES CARE
- Type 1 diabetes in older adults: Comparing treatments and chronic complications in the United States T1D Exchange and the German/Austrian DPV registries
- (2016) Ruth S. Weinstock et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Genetic risk factors for type 1 diabetes
- (2016) Flemming Pociot et al. LANCET
- Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes
- (2016) Jenny Aurielle B Babon et al. NATURE MEDICINE
- Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression
- (2016) Christian Hundhausen et al. Science Translational Medicine
- Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
- (2016) John A. Todd et al. PLOS MEDICINE
- Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
- (2016) Thomas Fremming Dejgaard et al. Lancet Diabetes & Endocrinology
- Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study
- (2015) Christian S. Frandsen et al. DIABETES CARE
- Efficacy and Safety of Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes
- (2015) Robert R. Henry et al. DIABETES CARE
- Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
- (2015) Anne L. Peters et al. DIABETES CARE
- Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes
- (2015) Ezio Bonifacio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes
- (2015) Ingrid M. Libman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SGLT2 Inhibitors May Predispose to Ketoacidosis
- (2015) Simeon I. Taylor et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
- (2015) Mark R. Rigby et al. JOURNAL OF CLINICAL INVESTIGATION
- Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis
- (2015) Amelia K. Linnemann et al. MOLECULAR ENDOCRINOLOGY
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study
- (2014) Kamlesh Khunti et al. DIABETES CARE
- Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
- (2014) Ronnie Aronson et al. DIABETES CARE
- Autoimmune Aspects of Type 2 Diabetes Mellitus - A Mini-Review
- (2014) Bianca K. Itariu et al. GERONTOLOGY
- B Lymphocyte Depletion by CD20 Monoclonal Antibody Prevents Diabetes in Nonobese Diabetic Mice despite Isotype-Specific Differences in Fc R Effector Functions
- (2014) Y. Xiu et al. JOURNAL OF IMMUNOLOGY
- Progress in immune-based therapies for type 1 diabetes
- (2013) M. von Herrath et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
- (2013) K. C. Herold et al. DIABETES
- Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protege Trial
- (2013) W. Hagopian et al. DIABETES
- Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
- (2013) K. Timper et al. DIABETES CARE
- B-Lymphocyte Depletion With Rituximab and -Cell Function: Two-Year Results
- (2013) M. D. Pescovitz et al. DIABETES CARE
- Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
- (2013) Tihamer Orban et al. DIABETES CARE
- Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus
- (2013) Andrew E. Hogan et al. DIABETOLOGIA
- Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?
- (2013) S. J. Cleland et al. DIABETOLOGIA
- Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes
- (2013) Jing Lu Kroll et al. JOURNAL OF CLINICAL VIROLOGY
- Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells
- (2013) Young-Sun Lee et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
- (2013) Stephen E Gitelman et al. Lancet Diabetes & Endocrinology
- Preventing -Cell Loss and Diabetes With Calcium Channel Blockers
- (2012) G. Xu et al. DIABETES
- Improvements in the Life Expectancy of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study Cohort
- (2012) R. G. Miller et al. DIABETES
- Interleukin-21 Receptor-Mediated Signals Control Autoreactive T Cell Infiltration in Pancreatic Islets
- (2012) Tom L. Van Belle et al. IMMUNITY
- Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?
- (2011) Urs Christen et al. Cellular & Molecular Immunology
- Interleukin-21 Is Critically Required in Autoimmune and Allogeneic Responses to Islet Tissue in Murine Models
- (2011) Helen M. McGuire et al. DIABETES
- How Does Type 1 Diabetes Develop?: The Notion of Homicide or -Cell Suicide Revisited
- (2011) M. A. Atkinson et al. DIABETES
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- The use of metformin in type 1 diabetes: a systematic review of efficacy
- (2010) S. Vella et al. DIABETOLOGIA
- Autologous Hematopoietic Stem Cell Transplantation for Type 1 Diabetes
- (2009) Júlio C. Voltarelli et al. Annals of the New York Academy of Sciences
- Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients
- (2009) B. Keymeulen et al. BLOOD
- Interleukin-21 Is Required for the Development of Type 1 Diabetes in NOD Mice
- (2009) A. P.R. Sutherland et al. DIABETES
- Effects of Exenatide Alone and in Combination With Daclizumab on -Cell Function in Long-Standing Type 1 Diabetes
- (2009) K. I. Rother et al. DIABETES CARE
- Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot randomized, placebo-controlled, double-blind study
- (2009) L. Mastrandrea et al. DIABETES CARE
- The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes
- (2009) T J Wilkin INTERNATIONAL JOURNAL OF OBESITY
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth Study
- (2009) Lenna L Liu et al. PEDIATRIC DIABETES
- Concordance for Islet Autoimmunity among Monozygotic Twins
- (2008) Maria J. Redondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Adjunct Metformin Treatment in Patients with Type-1 Diabetes and Persistent Inadequate Glycaemic Control. A Randomized Study
- (2008) Søren Søgaard Lund et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More